|
1
|
European Association for the Study of the
Liver, . Electronic address: easloffice@easloffice.eu. European
Association for the Study of the Liver: EASL clinical practical
guidelines on the management of acute (fulminant) liver failure. J
Hepatol. 66:1047–1081. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rajendran P, Rengarajan T, Nandakumar N,
Palaniswami R, Nishigaki Y and Nishigaki I: Kaempferol, a potential
cytostatic and cure for inflammatory disorders. Eur J Med Chem.
86:103–112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sharifi-Rad M, Fokou PVT, Sharopov F,
Martorell M, Ademiluyi AO, Rajkovic J, Salehi B, Martins N, Iriti M
and Sharifi-Rad J: Antiulcer agents: From plant extracts to
phytochemicals in healing promotion. Molecules. 23:17512018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Imran M, Salehi B, Sharifi-Rad J, Aslam
Gondal T, Saeed F, Imran A, Shahbaz M, Tsouh Fokou PV, Umair Arshad
M, Khan H, et al: Kaempferol: A key emphasis to its anticancer
potential. Molecules. 24:22772019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mahobiya A, Singh TU, Rungsung S, Kumar T,
Chandrasekaran G, Parida S and Kumar D: Kaempferol-induces
vasorelaxation via endothelium-independent pathways in rat isolated
pulmonary artery. Pharmacol Rep. 70:863–874. 2018. View Article : Google Scholar
|
|
6
|
Torres-Villarreal D, Camacho A, Castro H,
Ortiz-Lopez R and de la Garza AL: Anti-obesity effects of
kaempferol by inhibiting adipogenesis and increasing lipolysis in
3T3-L1 cells. J Physiol Biochem. 75:83–88. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kashafi E, Moradzadeh M, Mohamadkhani A
and Erfanian S: Kaempferol increases apoptosis in human cervical
cancer HeLa cells via PI3K/AKT and telomerase pathways. Biomed
Pharmacother. 89:573–577. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu P, Meng X, Zheng H, Zeng Q, Chen T,
Wang W, Zhang X and Su J: Kaempferol attenuates ROS-Induced
hemolysis and the molecular mechanism of its induction of apoptosis
on bladder cancer. Molecules. 23:25922018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Murakami T, Kohno K, Ninomiya K, Matsuda H
and Yoshikawa M: Medicinal foodstuffs. XXV. Hepatoprotective
principle and structures of ionone glucoside, phenethyl glycoside,
and flavonol oligoglycosides from young seedpods of garden peas,
Pisum sativum L. Chem Pharm Bull (Tokyo). 49:1003–1008.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiong Q, Fan W, Tezuka Y, Adnyana IK,
Stampoulis P, Hattori M, Namba T and Kadota S: Hepatoprotective
effect of Apocynum venetum and its active constituents. Planta Med.
66:127–133. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Matsuda H, Ninomiya K, Shimoda H and
Yoshikawa M: Hepatoprotective principles from the flowers of Tilia
argentea (linden): Structure requirements of tiliroside and
mechanisms of action. Bioorg Med Chem. 10:707–712. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
García-Mediavilla V, Crespo I, Collado PS,
Esteller A, Sánchez-Campos S, Tuñón MJ and González-Gallego J: The
anti-inflammatory flavones quercetin and kaempferol cause
inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and
reactive C-protein, and down-regulation of the nuclear factor
kappaB pathway in chang liver cells. Eur J Pharmacol. 557:221–229.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsai MS, Wang YH, Lai YY, Tsou HK, Liou
GG, Ko JL and Wang SH: Kaempferol protects against
propacetamol-induced acute liver injury through CYP2E1
inactivation, UGT1A1 activation, and attenuation of oxidative
stress, inflammation and apoptosis in mice. Toxicol Lett.
290:97–109. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang H, Chen L, Zhang X, Xu L, Xie B, Shi
H, Duan Z, Zhang H and Ren F: Kaempferol protects mice from
d-GalN/LPS-induced acute liver failure by regulating the ER
stress-Grp78-CHOP signaling pathway. Biomed Pharmacother.
111:468–475. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
McEwan DG: Host-pathogen interactions and
subversion of autophagy. Essays Biochem. 61:687–697. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiao L, Zhang HL, Li DD, Yang KL, Tang J,
Li X, Ji J, Yu Y, Wu R, Ravichandran S, et al: Regulation of
glycolytic metabolism by autophagy in liver cancer involves
selective autophagic degradation of HK2 (hexokinase 2). Autophagy.
14:671–684. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Madrigal-Matute J and Cuervo AM:
Regulation of liver metabolism by autophagy. Gastroenterology.
150:328–339. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ren F, Zhang L, Zhang X, Shi H, Wen T, Bai
L, Zheng S, Chen Y, Chen D, Li L and Duan Z: Inhibition of glycogen
synthase kinase 3β promotes autophagy to protect mice from acute
liver failure mediated by peroxisome proliferator-activated
receptor α. Cell Death Dis. 7:e21512016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mignon A, Rouquet N, Fabre M, Martin S,
Pagès JC, Dhainaut JF, Kahn A, Briand P and Joulin V: LPS Challenge
in D-galactosamine-Sensitized mice accounts for caspase-dependent
fulminant hepatitis, not for septic shock. Am J Resp Crit Care Med.
159((4 Pt 1)): 1308–1315. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nakama T, Hirono S, Moriuchi A, Hasuike S,
Nagata K, Hori T, Ido A, Hayashi K and Tsubouchi H: Etoposide
prevents apoptosis in mouse liver with
D-galactosamine/lipopolysaccharide-induced fulminant hepatic
failure resulting in reduction of lethality. Hepatology.
33:1441–1450. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Miller S, Oleksy A, Perisic O and Williams
RL: Finding a fitting shoe for Cinderella: Searching for an
autophagy inhibitor. Autophagy. 6:805–807. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ahlberg J, Berkenstam A, Henell F and
Glaumann H: Degradation of short and long lived proteins in
isolated rat liver lysosomes. Effects of pH, temperature, and
proteolytic inhibitors. J Biol Chem. 260:5847–5854. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Karmen A, Wroblewski F and Ladue JS:
Transaminase activity in human blood. J Clin Invest. 34:126–131.
1955. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Klaunig JE, Goldblatt PJ, Hinton DE,
Lipsky MM, Chacko J and Trump BF: Mouse liver cell culture. I.
Hepatocyte isolation. In vitro. 17:913–925. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nguyen TB, Louie SM, Daniele JR, Tran Q,
Dillin A, Zoncu R, Nomura DK and Olzmann JA: DGAT1-Dependent lipid
droplet biogenesis protects mitochondrial function during
starvation-induced autophagy. Dev Cell. 42:9–21.e5. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang X, Ding J, Gou C, Wen T, Li L, Wang
X, Yang H, Liu D, Lou J, Chen D, et al: Qingchangligan formula
attenuates the inflammatory response to protect the liver from
acute failure induced by d-galactosamine/lipopolysaccharide in
mice. J Ethnopharmacol. 201:108–116. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Devi KS, Mishra D, Roy B, Ghosh SK and
Maiti TK: Assessing the immunomodulatory role of heteroglycan in a
tumor spheroid and macrophage co-culture model system. Carbohyd
Polym. 127:1–10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zang Y, Zhang L, Igarashi K and Yu C: The
anti-obesity and anti-diabetic effects of kaempferol glycosides
from unripe soybean leaves in high-fat-diet mice. Food Funct.
6:834–841. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Alkhalidy H, Moore W, Wang A, Luo J,
McMillan RP, Wang Y, Zhen W, Hulver MW and Liu D: Kaempferol
ameliorates hyperglycemia through suppressing hepatic
gluconeogenesis and enhancing hepatic insulin sensitivity in
diet-induced obese mice. J Nutr Biochem. 58:90–101. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bernal W and Wendon J: Acute liver
failure. N Engl J Med. 369:2525–2534. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ren F, Zhou L, Zhang X, Wen T, Shi H, Xie
B, Li Z, Chen D, Wang Z and Duan Z: Endoplasmic reticulum
stress-activated glycogen synthase kinase 3β aggravates liver
inflammation and hepatotoxicity in mice with acute liver failure.
Inflammation. 38:1151–1165. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zaccone P, Phillips J, Conget I, Gomis R,
Haskins K, Minty A, Bendtzen K, Cooke A and Nicoletti F:
Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes.
48:1522–1528. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nicoletti F, Mancuso G, Cusumano V, Di
Marco R, Zaccone P, Bendtzen K and Teti G: Prevention of
endotoxin-induced lethality in neonatal mice by interleukin-13. Eur
J Immunol. 27:1580–1583. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chung MJ, Pandey RP, Choi JW, Sohng JK,
Choi DJ and Park YI: Inhibitory effects of
kaempferol-3-O-rhamnoside on ovalbumin-induced lung inflammation in
a mouse model of allergic asthma. Int Immunopharmacol. 25:302–310.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Russo M and Russo GL: Autophagy inducers
in cancer. Biochem Pharmacol. 153:51–61. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fésüs L, Demény MÁ and Petrovski G:
Autophagy shapes inflammation. Antioxid Redox Sign. 14:2233–2243.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jiao M, Ren F, Zhou L, Zhang X, Zhang L,
Wen T, Wei L, Wang X, Shi H, Bai L, et al: Peroxisome
proliferator-activated receptor α activation attenuates the
inflammatory response to protect the liver from acute failure by
promoting the autophagy pathway. Cell Death Dis. 5:e13972014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Klionsky DJ, Abdelmohsen K, Abe A, Abedin
MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD,
Adeli K, et al: Guidelines for the use and interpretation of assays
for monitoring autophagy (3rd edition). Autophagy. 12:1–222. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nicoletti F, Fagone P, Meroni P, McCubrey
J and Bendtzen K: mTOR as a multifunctional therapeutic target in
HIV infection. Drug Discov Today. 16:715–721. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Donia M, McCubrey JA, Bendtzen K and
Nicoletti F: Potential use of rapamycin in HIV infection. Br J Clin
Pharmacol. 70:784–793. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nicoletti F, Lapenta C, Donati S, Spada M,
Ranazzi A, Cacopardo B, Mangano K, Belardelli F, Perno C and Aquaro
S: Inhibition of human immunodeficiency virus (HIV-1) infection in
human peripheral blood leucocytes-SCID reconstituted mice by
rapamycin. Clin Exp Immunol. 155:28–34. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fagone P, Ciurleo R, Lombardo SD,
Iacobello C, Palermo CI, Shoenfeld Y, Bendtzen K, Bramanti P and
Nicoletti F: Transcriptional landscape of SARS-CoV-2 infection
dismantles pathogenic pathways activated by the virus, proposes
unique sex-specific differences and predicts tailored therapeutic
strategies. Autoimmun Rev. 19:1025712020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mammana S, Bramanti P, Mazzon E, Cavalli
E, Basile MS, Fagone P, Petralia MC, McCubrey JA, Nicoletti F and
Mangano K: Preclinical evaluation of the PI3K/Akt/mTOR pathway in
animal models of multiple sclerosis. Oncotarget. 9:8263–8277. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Donia M, Mangano K, Amoroso A, Mazzarino
MC, Imbesi R, Castrogiovanni P, Coco M, Meroni P and Nicoletti F:
Treatment with rapamycin ameliorates clinical and histological
signs of protracted relapsing experimental allergic
encephalomyelitis in Dark Agouti rats and induces expansion of
peripheral CD4+CD25+Foxp3+ regulatory T cells. J Autoimmun.
33:135–140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ji L, Xie W and Zhang Z: Efficacy and
safety of sirolimus in patients with systemic lupus erythematosus:
A systematic review and meta-analysis. Semin Arthritis Rheum.
50:1073–1080. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Xiao W, Liu Y, Dai M, Li Y, Peng R, Yu S
and Liu H: Rotenone restrains colon cancer cell viability, motility
and epithelial-mesenchymal transition and tumorigenesis in nude
mice via the PI3K/AKT pathway. Int J Mol Med. 46:700–708. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang Z, Li N, Liu S, Jiang M, Wan J,
Zhang Y, Wan L, Xie C and Le A: Overexpression of IFIT2 inhibits
the proliferation of chronic myeloid leukemia cells by regulating
the BCR-ABL/AKT/mTOR pathway. Int J Mol Med. 45:1187–1194.
2020.PubMed/NCBI
|
|
49
|
Liu Z, Liu H, Li Y, Wang Y, Xing R, Mi F,
Xiang C and Fu R: Adiponectin inhibits the differentiation and
maturation of osteoclasts via the mTOR pathway in multiple myeloma.
Int J Mol Med. 45:1112–1120. 2020.PubMed/NCBI
|
|
50
|
Cheng X, Yang YL, Yang H, Wang YH and Du
GH: Kaempferol alleviates LPS-induced neuroinflammation and BBB
dysfunction in mice via inhibiting HMGB1 release and
down-regulating TLR4/MyD88 pathway. Int Immunopharmacol. 56:29–35.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Xu Y, Jagannath C, Liu XD, Sharafkhaneh A,
Kolodziejska KE and Eissa NT: Toll-like receptor 4 is a sensor for
autophagy associated with innate immunity. Immunity. 27:135–144.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Delgado MA, Elmaoued RA, Davis AS, Kyei G
and Deretic V: Toll-like receptors control autophagy. Embo J.
27:1110–1121. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Stojanovic I, Cuzzocrea S, Mangano K,
Mazzon E, Miljkovic D, Wang M, Donia M, Al Abed Y, Kim J, Nicoletti
F, et al: In vitro, ex vivo and in vivo immunopharmacological
activities of the isoxazoline compound VGX-1027: Modulation of
cytokine synthesis and prevention of both organ-specific and
systemic autoimmune diseases in murine models. Clin Immunol.
123:311–323. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Fagone P, Muthumani K, Mangano K, Magro G,
Meroni PL, Kim JJ, Sardesai NY, Weiner DB and Nicoletti F: VGX-1027
modulates genes involved in lipopolysaccharide-induced Toll-like
receptor 4 activation and in a murine model of systemic lupus
erythematosus. Immunology. 142:594–602. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Lee JC, Menacherry S, Diehl MC, Giffear
MD, White CJ, Juba R, Bagarazzi ML, Muthumani K, Boyer J, Agarwal
V, et al: Safety, bioavailability, and pharmacokinetics of
VGX-1027-A novel oral anti-inflammatory drug in healthy human
subjects. Clin Pharmacol Drug Dev. 5:91–101. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Huang C, Pan L, Lin F, Dai H and Fu R:
Monoclonal antibody against Toll-like receptor 4 attenuates
ventilator-induced lung injury in rats by inhibiting MyD88- and
NF-κB-dependent signaling. Int J Mol Med. 39:693–700. 2017.
View Article : Google Scholar : PubMed/NCBI
|
